Conventional Surgical Treatment of Hepatocellular Carcinoma

Clinics in Liver Disease

Volumn 15, Issue 2, 2011, Pages 353-370

  Earl, T Mark ^a   Chapman, William C ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Liver cancer; Surgical resection

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18;

ARTIFICIAL EMBOLISM; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER SCINTISCANNING; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; ECHOGRAPHY; HUMAN; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION; LIVER RESECTION; LIVER SCINTISCANNING; LIVER SURGERY; LIVER TRANSPLANTATION; OVERALL SURVIVAL; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE CARE; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION;

EID: 79959324874     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2011.03.008     Document Type: Review

References (113)

1. Llovet J.M., Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol 2003, 38(Suppl 1):S136-S149.
2. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334(11):693-699.
3. Tsoulfas G., Kawai T., Elias N., et al. Long-term experience with liver transplantation for hepatocellular carcinoma. J Gastroenterol 2011, 46(2):249-256.
4. Island E.R., Pomposelli J., Pomfret E.A., et al. Twenty-year experience with liver transplantation for hepatocellular carcinoma. Arch Surg 2005, 140(4):353-358.
5. Trevisani F., Cantarini M.C., Labate A.M., et al. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol 2004, 99(8):1470-1476.
6. Tong M.J., Blatt L.M., Kao V.W. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol 2001, 16(5):553-559.
7. Zhang B.H., Yang B.H., Tang Z.Y. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 2004, 130(7):417-422.
8. Yuen M.F., Cheng C.C., Lauder I.J., et al. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology 2000, 31(2):330-335.
9. Sharma P., Balan V., Hernandez J.L., et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004, 10(1):36-41.
10. Washburn K. Model for end stage liver disease and hepatocellular carcinoma: a moving target. Transplant Rev (Orlando) 2010, 24(1):11-17.
11. Bruix J., Llovet J.M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002, 35(3):519-524.
12. Bismuth H., Chiche L., Adam R., et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993, 218(2):145-151.
13. Llovet J.M., Fuster J., Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999, 30(6):1434-1440.
14. Poon R.T., Fan S.T., Lo C.M., et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg 2001, 234(1):63-70.
15. Belghiti J., Regimbeau J.M., Durand F., et al. Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 2002, 49(43):41-46.
16. Cha C.H., Ruo L., Fong Y., et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 2003, 238(3):315-321. [discussion: 321-3].
17. Bralet M.P., Regimbeau J.M., Pineau P., et al. Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000, 32(2):200-204.
18. Trevisani F., D'Intino P.E., Caraceni P., et al. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients. Cancer 1995, 75(9):2220-2232.
19. Trevisani F., De N.S., Rapaccini G., et al. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol 2002, 97(3):734-744.
20. Wong L.L., Limm W.M., Severino R., et al. Improved survival with screening for hepatocellular carcinoma. Liver Transpl 2000, 6(3):320-325.
21. Pateron D., Ganne N., Trinchet J.C., et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994, 20(1):65-71.
22. Sherman M. Alphafetoprotein: an obituary. J Hepatol 2001, 34(4):603-605.
23. Lencioni R. Surveillance and early diagnosis of hepatocellular carcinoma. Dig Liver Dis 2010, 42(Suppl 3):S223-S227.
24. Bilimoria M.M., Lauwers G.Y., Doherty D.A., et al. Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 2001, 136(5):528-535.
25. Llovet J.M., Fuster J., Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 2004, 10(2 Suppl 1):S115-S120.
26. Yao F.Y., Bass N.M., Nikolai B., et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002, 8(10):873-883.
27. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001, 33(6):1394-1403.
28. Bharat A., Brown D.B., Crippin J.S., et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 2006, 203(4):411-420.
29. Chapman W.C., Majella Doyle M.B., Stuart J.E., et al. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation. Ann Surg 2008, 248(4):617-625.
30. Grando-Lemaire V., Guettier C., Chevret S., et al. Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol 1999, 31(3):508-513.
31. El-Serag H.B., Davila J.A. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study. Hepatology 2004, 39(3):798-803.
32. Poon R.T., Fan S.T., Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 2002, 194(5):592-602.
33. Belghiti J., Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford) 2005, 7(1):42-49.
34. Yuki K., Hirohashi S., Sakamoto M., et al. Growth and spread of hepatocellular carcinoma. A review of 240 consecutive autopsy cases. Cancer 1990, 66(10):2174-2179.
35. Koneru B., Teperman L.W., Manzarbeitia C., et al. A multicenter evaluation of utility of chest computed tomography and bone scans in liver transplant candidates with stages I and II hepatoma. Ann Surg 2005, 241(4):622-628.
36. Yoon K.T., Kim J.K., Kim do Y., et al. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma. Oncology 2007, 72(Suppl 1):104-110.
37. UNOS Liver Allocation Policy 3.6.4.4(i) 2010, UNOS. UNOS (Ed.).
38. Khan M.A., Combs C.S., Brunt E.M., et al. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 2000, 32(5):792-797.
39. Wolfort R.M., Papillion P.W., Turnage R.H., et al. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade. Int Surg 2010, 95(1):67-75.
40. Young A.L., Malik H.Z., Abu-Hilal M., et al. Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg 2007, 205(3):453-462.
41. Pawlik T.M., Poon R.T., Abdalla E.K., et al. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 2005, 140(5):450-457. [discussion: 457-8].
42. Ng K.K., Vauthey J.N., Pawlik T.M., et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 2005, 12(5):364-373.
43. Wang B.W., Mok K.T., Liu S.I., et al. Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma?. J Formos Med Assoc 2008, 107(8):616-626.
44. Ikai I., Yamamoto Y., Yamamoto N., et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am 2003, 12(1):65-75. ix.
45. Pawlik T.M., Poon R.T., Abdalla E.K., et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 2005, 137(4):403-410.
46. Yeh C.N., Jan Y.Y., Lee W.C., et al. Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg 2004, 28(5):471-475.
47. Ikenaga N., Chijiiwa K., Otani K., et al. Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J Gastrointest Surg 2009, 13(3):492-497.
48. Franco D., Capussotti L., Smadja C., et al. Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis. Gastroenterology 1990, 98(3):733-738.
49. Garrison R.N., Cryer H.M., Howard D.A., et al. Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984, 199(6):648-655.
50. Mansour A., Watson W., Shayani V., et al. Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 1997, 122(4):730-735. [discussion: 735-6].
51. Telem D.A., Schiano T., Goldstone R., et al. Factors that predict outcome of abdominal operations in patients with advanced cirrhosis. Clin Gastroenterol Hepatol 2010, 8(5):451-457. [quiz: e458].
52. Befeler A.S., Palmer D.E., Hoffman M., et al. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg 2005, 140(7):650-654. [discussion: 655].
53. Farnsworth N., Fagan S.P., Berger D.H., et al. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg 2004, 188(5):580-583.
54. Perkins L., Jeffries M., Patel T. Utility of preoperative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol 2004, 2(12):1123-1128.
55. Delis S.G., Bakoyiannis A., Biliatis I., et al. Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma. HPB (Oxford) 2009, 11(4):351-357.
56. Hsu K.Y., Chau G.Y., Lui W.Y., et al. Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg 2009, 33(11):2412-2419.
57. Cucchetti A., Ercolani G., Vivarelli M., et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 2006, 12(6):966-971.
58. Teh S.H., Christein J., Donohue J., et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage liver disease (MELD) score predicts perioperative mortality. J Gastrointest Surg 2005, 9(9):1207-1215. [discussion: 1215].
59. Vauthey J.N., Pawlik T.M., Abdalla E.K., et al. Is extended hepatectomy for hepatobiliary malignancy justified?. Ann Surg 2004, 239(5):722-730. [discussion: 730-2].
60. Ribero D., Abdalla E.K., Madoff D.C., et al. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 2007, 94(11):1386-1394.
61. Kishi Y., Abdalla E.K., Chun Y.S., et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry. Ann Surg 2009, 250(4):540-548.
62. Dixon E., Abdalla E., Schwarz R.E., et al. AHPBA/SSO/SSAT Sponsored Consensus Conference on Multidisciplinary Treatment of Hepatocellular Carcinoma. HPB (Oxford) 2010, 12(5):287-288.
63. Okochi O., Kaneko T., Sugimoto H., et al. ICG pulse spectrophotometry for perioperative liver function in hepatectomy. J Surg Res 2002, 103(1):109-113.
64. Lau H., Man K., Fan S.T., et al. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 1997, 84(9):1255-1259.
65. Lam C.M., Fan S.T., Lo C.M., et al. Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 1999, 86(8):1012-1017.
66. Bruix J., Castells A., Bosch J., et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 1996, 111(4):1018-1022.
67. Cucchetti A., Ercolani G., Vivarelli M., et al. Is portal hypertension a contraindication to hepatic resection?. Ann Surg 2009, 250(6):922-928.
68. Ziser A., Plevak D.J., Wiesner R.H., et al. Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology 1999, 90(1):42-53.
69. Teh S.H., Nagorney D.M., Stevens S.R., et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007, 132(4):1261-1269.
70. Kinoshita H., Sakai K., Hirohashi K., et al. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 1986, 10(5):803-808.
71. Kubota K., Makuuchi M., Kusaka K., et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997, 26(5):1176-1181.
72. Shirabe K., Shimada M., Gion T., et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg 1999, 188(3):304-309.
73. Abulkhir A., Limongelli P., Healey A.J., et al. Preoperative portal vein embolization for major liver resection: a meta-analysis. Ann Surg 2008, 247(1):49-57.
74. Farges O., Belghiti J., Kianmanesh R., et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 2003, 237(2):208-217.
75. Palavecino M., Chun Y.S., Madoff D.C., et al. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: perioperative outcome and survival. Surgery 2009, 145(4):399-405.
76. Vauthey J.N., Dixon E., Abdalla E.K., et al. Pretreatment assessment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 2010, 12(5):289-299.
77. Zhou W.P., Lai E.C., Li A.J., et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg 2009, 249(2):195-202.
78. Chua T.C., Liauw W., Saxena A., et al. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma. Liver Int 2010, 30(2):166-174.
79. Fan S.T., Lo C.M., Liu C.L., et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999, 229(3):322-330.
80. Bryant R., Laurent A., Tayar C., et al. Liver resection for hepatocellular carcinoma. Surg Oncol Clin N Am 2008, 17(3):607-633. ix.
81. Chen H., Merchant N.B., Didolkar M.S. Hepatic resection using intermittent vascular inflow occlusion and low central venous pressure anesthesia improves morbidity and mortality. J Gastrointest Surg 2000, 4(2):162-167.
82. Pamecha V., Gurusamy K.S., Sharma D., et al. Techniques for liver parenchymal transection: a meta-analysis of randomized controlled trials. HPB (Oxford) 2009, 11(4):275-281.
83. Gurusamy K.S., Pamecha V., Sharma D., et al. Techniques for liver parenchymal transection in liver resection. Cochrane Database Syst Rev 2009, 1. CD006880.
84. Katz S.C., Shia J., Liau K.H., et al. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma. Ann Surg 2009, 249(4):617-623.
85. Poon R.T., Fan S.T., Lo C.M., et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 1999, 229(2):216-222.
86. Man K., Fan S.T., Ng I.O., et al. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997, 226(6):704-711. [discussion: 711-3].
87. Chen J., Huang K., Wu J., et al. Survival after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis. Dig Dis Sci 2010, [Epub ahead of print].
88. Dahiya D., Wu T.J., Lee C.F., et al. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience. Surgery 2010, 147(5):676-685.
89. Poon R.T., Fan S.T., Ng I.O., et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg 2000, 231(4):544-551.
90. Shi M., Guo R.P., Lin X.J., et al. Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 2007, 245(1):36-43.
91. Jarnagin W., Chapman W.C., Curley S., et al. Surgical treatment of hepatocellular carcinoma: expert consensus statement. HPB (Oxford) 2010, 12(5):302-310.
92. Chouillard E., Cherqui D., Tayar C., et al. Anatomical bi- and trisegmentectomies as alternatives to extensive liver resections. Ann Surg 2003, 238(1):29-34.
93. Lai E.C., Fan S.T., Lo C.M., et al. Anterior approach for difficult major right hepatectomy. World J Surg 1996, 20(3):314-317. [discussion: 318].
94. Liu C.L., Fan S.T., Cheung S.T., et al. Anterior approach versus conventional approach right hepatic resection for large hepatocellular carcinoma: a prospective randomized controlled study. Ann Surg 2006, 244(2):194-203.
95. Belghiti J., Guevara O.A., Noun R., et al. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg 2001, 193(1):109-111.
96. Meng W.C., Shao C.X., Mak K.L., et al. Anatomical justification of Belghiti's 'liver hanging manoeuvre' in right hepatectomy with anterior approach. ANZ J Surg 2003, 73(6):407-409.
97. Wu T.J., Wang F., Lin Y.S., et al. Right hepatectomy by the anterior method with liver hanging versus conventional approach for large hepatocellular carcinomas. Br J Surg 2010, 97(7):1070-1078.
98. Huang J., Yan L., Cheng Z., et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010, 252(6):903-912.
99. Ikai I., Arii S., Okazaki M., et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 2007, 37(9):676-691.
100. Cha C., Fong Y., Jarnagin W.R., et al. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg 2003, 197(5):753-758.
101. Chen M.F., Jeng L.B. Partial hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 1997, 12(9-10):S329-S334.
102. Nagasue N., Kohno H., Chang Y.C., et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg 1993, 217(4):375-384.
103. Shimozawa N., Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 2004, 198(3):356-365.
104. Vauthey J.N., Klimstra D., Franceschi D., et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995, 169(1):28-34. [discussion: 34-5].
105. Ercolani G., Grazi G.L., Ravaioli M., et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003, 237(4):536-543.
106. Esnaola N.F., Mirza N., Lauwers G.Y., et al. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg 2003, 238(5):711-719.
107. Li Q., Wang J., Juzi J.T., et al. Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma. J Gastrointest Surg 2008, 12(9):1540-1547.
108. Ng I.O., Guan X.Y., Poon R.T., et al. Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J Pathol 2003, 199(3):345-353.
109. Poon R.T., Fan S.T., Lo C.M., et al. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002, 235(3):373-382.
110. Imamura H., Matsuyama Y., Tanaka E., et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003, 38(2):200-207.
111. Poon R.T., Fan S.T., O'Suilleabhain C.B., et al. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. J Am Coll Surg 2002, 195(3):311-318.
112. Del Gaudio M., Ercolani G., Ravaioli M., et al. Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: university of bologna experience. Am J Transplant 2008, 8(6):1177-1185.
113. Adam R., Azoulay D. Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy?. Ann Surg 2005, 241(4):671-672.